Sepsis-induced cardiac mitochondrial damage and potential therapeutic interventions in the elderly

Aging and Disease

Volumn 5, Issue 2, 2014, Pages 137-149

  Zang, Qun S ^a   Wolf, Steven E ^a   Minei, Joseph P ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Autophagy; Cardiac function; Inflammation; Mitochondria; Mitochondria targeted antioxidants; Sepsis

Indexed keywords

ANIMALIA;

EID: 84916880575     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0500137     Document Type: Review

References (189)

1. Angus DC, Pereira CA, Silva E (2006). Epidemiology of severe sepsis around the world. Endocr Metab Immune Disord Drug Targets, 6: 207-212
2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101: 1644-1655
3. Moss M, Martin GS (2004). A global perspective on the epidemiology of sepsis. Intensive care medicine, 30: 527-529
4. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med, 38: 367-374
5. O'Brien JM, Jr., Ali NA, Aberegg SK, Abraham E (2007). Sepsis. Am J Med, 120: 1012-1022
6. Marik PE (2006). Management of the critically ill geriatric patient. Critical care medicine, 34: S176-182
7. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001). Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical care medicine, 29: 1303-1310
8. Martin GS, Mannino DM, Moss M (2006). The effect of age on the development and outcome of adult sepsis. Critical care medicine, 34: 15-21
9. Nasa P, Juneja D, Singh O, Dang R, Arora V (2012). Severe sepsis and its impact on outcome in elderly and very elderly patients admitted in intensive care unit. Journal of intensive care medicine, 27: 179-183
10. Iwashyna TJ, Ely EW, Smith DM, Langa KM (2010). Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA: the journal of the American Medical Association, 304: 1787-1794
11. Franceschi C, Bonafe M, Valensin S (2000). Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine, 18: 1717-1720
12. Miller RA (2000). Effect of aging on T lymphocyte activation. Vaccine, 18: 1654-1660
13. Weksler ME (2000). Changes in the B-cell repertoire with age. Vaccine, 18: 1624-1628
14. Grubeck-Loebenstein B, Wick G (2002). The aging of the immune system. Advances in immunology, 80: 243-284
15. Plackett TP, Boehmer ED, Faunce DE, Kovacs EJ (2004). Aging and innate immune cells. Journal of leukocyte biology, 76: 291-299
16. Sanchez M, Lindroth K, Sverremark E, Gonzalez Fernandez A, Fernandez C (2001). The response in old mice: positive and negative immune memory after priming in early age. International immunology, 13: 1213-1221
17. Lebecque S (2000). Antigen receptors and dendritic cells. Vaccine, 18: 1603-1605
18. Herrero C, Marques L, Lloberas J, Celada A (2001). IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. The Journal of clinical investigation, 107: 485-493
19. Gabriel P, Cakman I, Rink L (2002). Overproduction of monokines by leukocytes after stimulation with lipopolysaccharide in the elderly. Experimental gerontology, 37: 235-247
20. Bruunsgaard H, Skinhoj P, Qvist J, Pedersen BK (1999). Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. The Journal of infectious diseases, 180: 551-554
21. Jensen GL, McGee M, Binkley J (2001). Nutrition in the elderly. Gastroenterology clinics of North America, 30: 313-334
22. Chernow B (1999). Variables affecting outcome in critically ill patients. Chest, 115: 71S-76S
23. Stump TE, Callahan CM, Hendrie HC (2001). Cognitive impairment and mortality in older primary care patients. Journal of the American Geriatrics Society, 49: 934-940
24. Harman D (1956). Aging: a theory based on free radical and radiation chemistry. J Gerontol, 11: 298-300
25. Harrison R (2002). Structure and function of xanthine oxidoreductase: where are we now? Free radical biology & medicine, 33: 774-797
26. Bedard K, Krause KH (2007). The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiological reviews, 87: 245-313
27. Schrader M, Fahimi HD (2006). Peroxisomes and oxidative stress. Biochimica et biophysica acta, 1763: 1755-1766
28. Barja G (1998). Mitochondrial free radical production and aging in mammals and birds. Annals of the New York Academy of Sciences, 854: 224-238
29. Antunes F, Han D, Cadenas E (2002). Relative contributions of heart mitochondria glutathione peroxidase and catalase to H(2)O(2) detoxification in in vivo conditions. Free radical biology & medicine, 33: 1260-1267
30. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, et al. (1999). Mitochondrial disease in superoxide dismutase 2 mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 96: 846-851
31. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD, Freeman BA (1991). Detection of catalase in rat heart mitochondria. The Journal of biological chemistry, 266: 22028-22034
32. Beal MF (2002). Oxidatively modified proteins in aging and disease. Free radical biology & medicine, 32: 797-803
33. Croteau DL, Bohr VA (1997). Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. The Journal of biological chemistry, 272: 25409-25412
34. Harman D (1972). Free radical theory of aging: dietary implications. The American journal of clinical nutrition, 25: 839-843
35. Unlu ES, Koc A (2007). Effects of deleting mitochondrial antioxidant genes on life span. Annals of the New York Academy of Sciences, 1100: 505-509
36. Melov S, Ravenscroft J, Malik S, Gill MS, Walker DW, Clayton PE, et al. (2000). Extension of life-span with superoxide dismutase/catalase mimetics. Science, 289: 1567-1569
37. Lee HY, Choi CS, Birkenfeld AL, Alves TC, Jornayvaz FR, Jurczak MJ, et al. (2010). Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell metabolism, 12: 668-674
38. Schriner SE, Linford NJ, Martin GM, Treuting P, Ogburn CE, Emond M, et al. (2005). Extension of murine life span by overexpression of catalase targeted to mitochondria. Science, 308: 1909-1911
39. Perez VI, Van Remmen H, Bokov A, Epstein CJ, Vijg J, Richardson A (2009). The overexpression of major antioxidant enzymes does not extend the lifespan of mice. Aging cell, 8: 73-75
40. Dolara P, Bigagli E, Collins A (2012). Antioxidant vitamins and mineral supplementation, life span expansion and cancer incidence: a critical commentary. European journal of nutrition, 51: 769-781
41. Kayar SR, Banchero N (1987). Volume density and distribution of mitochondria in myocardial growth and hypertrophy. Respir Physiol, 70: 275-286
42. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C (2005). Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 19: 419-421
43. Dai DF, Rabinovitch PS, Ungvari Z (2012). Mitochondria and cardiovascular aging. Circulation research, 110: 1109-1124
44. Dai DF, Hsieh EJ, Liu Y, Chen T, Beyer RP, Chin MT, et al. (2012). Mitochondrial proteome remodelling in pressure overload-induced heart failure: the role of mitochondrial oxidative stress. Cardiovascular research, 93: 79-88
45. Dai DF, Johnson SC, Villarin JJ, Chin MT, Nieves-Cintron M, Chen T, et al. (2011). Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure. Circulation research, 108: 837-846
46. Dai DF, Santana LF, Vermulst M, Tomazela DM, Emond MJ, MacCoss MJ, et al. (2009). Overexpression of catalase targeted to mitochondria attenuates murine cardiac aging. Circulation, 119: 2789-2797
47. Shen X, Zheng S, Metreveli NS, Epstein PN (2006). Protection of cardiac mitochondria by overexpression of MnSOD reduces diabetic cardiomyopathy. Diabetes, 55: 798-805
48. Loch T, Vakhrusheva O, Piotrowska I, Ziolkowski W, Ebelt H, Braun T, et al. (2009). Different extent of cardiac malfunction and resistance to oxidative stress in heterozygous and homozygous manganese-dependent superoxide dismutase-mutant mice. Cardiovascular research, 82: 448-457
49. Court O, Kumar A, Parrillo JE (2002). Clinical review: Myocardial depression in sepsis and septic shock. Crit Care, 6: 500-508
50. Zanotti-Cavazzoni SL, Hollenberg SM (2009). Cardiac dysfunction in severe sepsis and septic shock. Curr Opin Crit Care, 15: 392-397
51. Rudiger A, Singer M (2007). Mechanisms of sepsis-induced cardiac dysfunction. Critical care medicine, 35: 1599-1608
52. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, Tamayo L, et al. (2008). Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care, 12: R158
53. Parrillo JE, Parker MM, Natanson C, Suffredini AF, Danner RL, Cunnion RE, et al. (1990). Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Annals of internal medicine, 113: 227-242
54. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, et al. (2002). Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet, 360: 219-223
55. Cairns CB, Moore FA, Haenel JB, Gallea BL, Ortner JP, Rose SJ, et al. (1997). Evidence for early supply independent mitochondrial dysfunction in patients developing multiple organ failure after trauma. The Journal of trauma, 42: 532-536
56. Watts JA, Kline JA, Thornton LR, Grattan RM, Brar SS (2004). Metabolic dysfunction and depletion of mitochondria in hearts of septic rats. Journal of molecular and cellular cardiology, 36: 141-150
57. Levy RJ (2007). Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock, 28: 24-28
58. Callahan LA, Supinski GS (2007). Diaphragm and cardiac mitochondrial creatine kinases are impaired in sepsis. J Appl Physiol, 102: 44-53
59. Akira S, Uematsu S, Takeuchi O (2006). Pathogen recognition and innate immunity. Cell, 124: 783-801
60. Matzinger P (1994). Tolerance, danger, and the extended family. Annu Rev Immunol, 12: 991-1045
61. Codina R, Vanasse A, Kelekar A, Vezys V, Jemmerson R (2010). Cytochrome c-induced lymphocyte death from the outside in: inhibition by serum leucine-rich alpha-2-glycoprotein-1. Apoptosis, 15: 139-152
62. Creagh EM, O'Neill LA (2006). TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol, 27: 352-357
63. Uematsu S, Akira S (2006). Toll-like receptors and innate immunity. J Mol Med, 84: 712-725
64. Geijtenbeek TB, Gringhuis SI (2009). Signalling through C-type lectin receptors: shaping immune responses. Nature reviews. Immunology, 9: 465-479
65. Osorio F, Reise Sousa C (2011). Myeloid C-type lectin receptors in pathogen recognition and host defense. Immunity, 34: 651-664
66. Orange JS, Geha RS (2003). Finding NEMO: genetic disorders of NF-[kappa]B activation. J Clin Invest, 112: 983-985
67. Israel A (2000). The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol, 10: 129-133
68. Cinel I, Opal SM (2009). Molecular biology of inflammation and sepsis: a primer. Critical care medicine, 37: 291-304
69. Martinon F, Mayor A, Tschopp J (2009). The inflammasomes: guardians of the body. Annu Rev Immunol, 27: 229-265
70. Lee MS, Kim YJ (2007). Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem, 76: 447-480
71. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. (2010). Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature, 464: 104-107
72. Carp H (1982). Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med, 155: 264-275
73. Czapiga M, Gao JL, Kirk A, Lekstrom-Himes J (2005). Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol, 33: 73-84
74. Bjorkman L, Karlsson J, Karlsson A, Rabiet MJ, Boulay F, Fu H, et al. (2008). Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. Journal of leukocyte biology, 83: 245-253
75. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. (2009). Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nature medicine, 15: 1170-1178
76. Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, et al. (2009). Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proceedings of the National Academy of Sciences of the United States of America, 106: 20388-20393
77. Pullerits R, Bokarewa M, Jonsson IM, Verdrengh M, Tarkowski A (2005). Extracellular cytochrome c, a mitochondrial apoptosis-related protein, induces arthritis. Rheumatology (Oxford), 44: 32-39
78. Zhang Q, Itagaki K, Hauser CJ MITOCHONDRIAL DNA IS RELEASED BY SHOCK AND ACTIVATES NEUTROPHILS VIA p38 MAP-KINASE. Shock,
79. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature, 464: 104-107
80. Zhou R, Yazdi AS, Menu P, Tschopp J (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature, 469: 221-225
81. Seth RB, Sun L, Ea CK, Chen ZJ (2005). Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell, 122: 669-682
82. Tsutsui H, Kinugawa S, Matsushima S (2008). Oxidative stress and mitochondrial DNA damage in heart failure. Circ J, 72 Suppl A: A31-37
83. Ballinger SW (2005). Mitochondrial dysfunction in cardiovascular disease. Free radical biology & medicine, 38: 1278-1295
84. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR (2006). Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res, 72: 384-393
85. Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, Rudiger M, et al. (2008). Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Cardiovasc Res, 78: 26-35
86. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, et al. (2009). Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol, 22: 311-322
87. Neviere R, Fauvel H, Chopin C, Formstecher P, Marchetti P (2001). Caspase inhibition prevents cardiac dysfunction and heart apoptosis in a rat model of sepsis. Am J Respir Crit Care Med, 163: 218-225
88. Schmidt C, Kurt B, Hocherl K, Bucher M (2009). Inhibition of NF-kappaB activity prevents downregulation of alpha1-adrenergic receptors and circulatory failure during CLP-induced sepsis. Shock, 32: 239-246
89. Zang QS, Sadek H, Maass DL, Martinez B, Ma L, Kilgore JA, et al. (2012). Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model. American journal of physiology. Heart and circulatory physiology, 302: H1847-1859
90. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, et al. (2012). Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature, 485: 251-255
91. Greenhalgh DG, Saffle JR, Holmes JHt, Gamelli RL, Palmieri TL, Horton JW, et al. (2007). American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res, 28: 776-790
92. Wang L, Quan J, Johnston WE, Maass DL, Horton JW, Thomas JA, et al. (2010). Age-dependent differences of interleukin-6 activity in cardiac function after burn complicated by sepsis. Burns, 36: 232-238
93. Sheeran PW, Maass DL, White DJ, Turbeville TD, Giroir BP, Horton JW (1998). Aspiration pneumonia-induced sepsis increases cardiac dysfunction after burn trauma. The Journal of surgical research, 76: 192-199
94. White J, Thomas J, Maass DL, Horton JW (2003). Cardiac effects of burn injury complicated by aspiration pneumonia-induced sepsis. American journal of physiology. Heart and circulatory physiology, 285: H47-58
95. Tao W, Maass DL, Johnston WE, Horton JW (2005). Murine in vivo myocardial contractile dysfunction after burn injury is exacerbated by pneumonia sepsis. Shock, 24: 495-499
96. Zang Q, Maass DL, Tsai SJ, Horton JW (2007). Cardiac mitochondrial damage and inflammation responses in sepsis. Surg Infect (Larchmt), 8: 41-54
97. Reynolds CM, Suliman HB, Hollingsworth JW, Welty-Wolf KE, Carraway MS, Piantadosi CA (2009). Nitric oxide synthase-2 induction optimizes cardiac mitochondrial biogenesis after endotoxemia. Free radical biology & medicine, 46: 564-572
98. Fauconnier J, Meli AC, Thireau J, Roberge S, Shan J, Sassi Y, et al. Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion. Proceedings of the National Academy of Sciences of the United States of America,
99. Mizushima N, Levine B (2010). Autophagy in mammalian development and differentiation. Nat Cell Biol, 12: 823-830
100. Yamamoto S, Sawada K, Shimomura H, Kawamura K, James TN (2000). On the nature of cell death during remodeling of hypertrophied human myocardium. Journal of molecular and cellular cardiology, 32: 161-175
101. Yan L, Vatner DE, Kim SJ, Ge H, Masurekar M, Massover WH, et al. (2005). Autophagy in chronically ischemic myocardium. Proceedings of the National Academy of Sciences of the United States of America, 102: 13807-13812
102. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, et al. (2007). Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circulation research, 100: 914-922
103. Zhu H, Rothermel BA, Hill JA (2009). Autophagy in load-induced heart disease. Methods Enzymol, 453: 343-363
104. Zhu H, Tannous P, Johnstone JL, Kong Y, Shelton JM, Richardson JA, et al. (2007). Cardiac autophagy is a maladaptive response to hemodynamic stress. The Journal of clinical investigation, 117: 1782-1793
105. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 402: 672-676
106. Kroemer G, Marino G, Levine B (2010). Autophagy and the integrated stress response. Mol Cell, 40: 280-293
107. Levine B, Kroemer G (2008). Autophagy in the pathogenesis of disease. Cell, 132: 27-42
108. Tannous P, Zhu H, Johnstone JL, Shelton JM, Rajasekaran NS, Benjamin IJ, et al. (2008). Autophagy is an adaptive response in desmin-related cardiomyopathy. Proceedings of the National Academy of Sciences of the United States of America, 105: 9745-9750
109. Hill JA (2011). Autophagy in cardiac plasticity and disease. Pediatr Cardiol, 32: 282-289
110. Ferdous A, Battiprolu PK, Ni YG, Rothermel BA, Hill JA (2010). FoxO, autophagy, and cardiac remodeling. Journal of cardiovascular translational research, 3: 355-364
111. Xie M, Morales CR, Lavandero S, Hill JA (2011). Tuning flux: autophagy as a target of heart disease therapy. Curr Opin Cardiol, 26: 216-222
112. Inuzuka Y, Okuda J, Kawashima T, Kato T, Niizuma S, Tamaki Y, et al. (2009). Suppression of phosphoinositide 3-kinase prevents cardiac aging in mice. Circulation, 120: 1695-1703
113. Taneike M, Yamaguchi O, Nakai A, Hikoso S, Takeda T, Mizote I, et al. (2010). Inhibition of autophagy in the heart induces age-related cardiomyopathy. Autophagy, 6: 600-606
114. Sachs HG, Colgan JA, Lazarus ML (1977). Ultrastructure of the aging myocardium: a morphometric approach. The American journal of anatomy, 150: 63-71
115. Coleman R, Silbermann M, Gershon D, Reznick AZ (1987). Giant mitochondria in the myocardium of aging and endurance-trained mice. Gerontology, 33: 34-39
116. Levine B, Mizushima N, Virgin HW (2011). Autophagy in immunity and inflammation. Nature, 469: 323-335
117. Cuervo AM, Dice JF (2000). When lysosomes get old. Experimental gerontology, 35: 119-131
118. Nakano M, Oenzil F, Mizuno T, Gotoh S (1995). Age-related changes in the lipofuscin accumulation of brain and heart. Gerontology, 41 Suppl 2: 69-79
119. Brunk UT, Terman A (2002). Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free radical biology & medicine, 33: 611-619
120. Mofarrahi M, Sigala I, Guo Y, Godin R, Davis EC, Petrof B, et al. (2012). Autophagy and skeletal muscles in sepsis. PloS one, 7: e47265
121. Hsiao HW, Tsai KL, Wang LF, Chen YH, Chiang PC, Chuang SM, et al. (2012). The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock, 37: 289-296
122. Chien WS, Chen YH, Chiang PC, Hsiao HW, Chuang SM, Lue SI, et al. (2011). Suppression of autophagy in rat liver at late stage of polymicrobial sepsis. Shock, 35: 506-511
123. Watanabe E, Muenzer JT, Hawkins WG, Davis CG, Dixon DJ, McDunn JE, et al. (2009). Sepsis induces extensive autophagic vacuolization in hepatocytes: a clinical and laboratory-based study. Laboratory investigation; a journal of technical methods and pathology, 89: 549-561
124. Li L, Chen Y, Gibson SB (2013). Starvation-induced autophagy is regulated by mitochondrial reactive oxygen species leading to AMPK activation. Cellular signalling, 25: 50-65
125. Lee J, Giordano S, Zhang J (2012). Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. The Biochemical journal, 441: 523-540
126. Morales CR, Pedrozo Z, Lavandero S, Hill JA (2013). Oxidative Stress and Autophagy in Cardiovascular Homeostasis. Antioxidants & redox signaling,
127. Hsieh CH, Pai PY, Hsueh HW, Yuan SS, Hsieh YC (2011). Complete induction of autophagy is essential for cardioprotection in sepsis. Annals of surgery, 253: 1190-1200
128. Yuan H, Perry CN, Huang C, Iwai-Kanai E, Carreira RS, Glembotski CC, et al. (2009). LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. American journal of physiology. Heart and circulatory physiology, 296: H470-479
129. Turdi S, Han X, Huff AF, Roe ND, Hu N, Gao F, et al. (2012). Cardiac-specific overexpression of catalase attenuates lipopolysaccharide-induced myocardial contractile dysfunction: role of autophagy. Free radical biology & medicine, 53: 1327-1338
130. Zang QS, Martinez B, Yao X, Maass DL, Ma L, Wolf SE, et al. (2012). Sepsis-Induced Cardiac Mitochondrial Dysfunction Involves Altered Mitochondrial-Localization of Tyrosine Kinase Src and Tyrosine Phosphatase SHP2. PloS one, 7: e43424
131. Tibaldi E, Brunati AM, Massimino ML, Stringaro A, Colone M, Agostinelli E, et al. (2008). Src-Tyrosine kinases are major agents in mitochondrial tyrosine phosphorylation. J Cell Biochem, 104: 840-849
132. Arachiche A, Augereau O, Decossas M, Pertuiset C, Gontier E, Letellier T, et al. (2008). Localization of PTP-1B, SHP-2, and Src exclusively in rat brain mitochondria and functional consequences. The Journal of biological chemistry, 283: 24406-24411
133. Budas GR, Churchill EN, Disatnik MH, Sun L, Mochly-Rosen D (2010). Mitochondrial import of PKCepsilon is mediated by HSP90: a role in cardioprotection from ischaemia and reperfusion injury. Cardiovascular research, 88: 83-92
134. Guo J, Cong L, Rybin VO, Gertsberg Z, Steinberg SF (2010). Protein kinase C-{delta} regulates the subcellular localization of Shc in H2O2-treated cardiomyocytes. American journal of physiology. Cell physiology, 299: C770-778
135. Alonso M, Melani M, Converso D, Jaitovich A, Paz C, Carreras MC, et al. (2004). Mitochondrial extracellular signal-regulated kinases 1/2 (ERK1/2) are modulated during brain development. J Neurochem, 89: 248-256
136. Monick MM, Powers LS, Barrett CW, Hinde S, Ashare A, Groskreutz DJ, et al. (2008). Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity. J Immunol, 180: 7485-7496
137. Miyazaki T, Neff L, Tanaka S, Horne WC, Baron R (2003). Regulation of cytochrome c oxidase activity by c-Src in osteoclasts. J Cell Biol, 160: 709-718
138. Feng J, Lucchinetti E, Enkavi G, Wang Y, Gehrig P, Roschitzki B, et al. (2010). Tyrosine phosphorylation by Src within the cavity of the adenine nucleotide translocase 1 regulates ADP/ATP exchange in mitochondria. American journal of physiology. Cell physiology, 298: C740-748
139. Lewandrowski U, Sickmann A, Cesaro L, Brunati AM, Toninello A, Salvi M (2008). Identification of new tyrosine phosphorylated proteins in rat brain mitochondria. FEBS Lett, 582: 1104-1110
140. Augereau O, Claverol S, Boudes N, Basurko MJ, Bonneu M, Rossignol R, et al. (2005). Identification of tyrosine-phosphorylated proteins of the mitochondrial oxidative phosphorylation machinery. Cell Mol Life Sci, 62: 1478-1488
141. Deng N, Zhang J, Zong C, Wang Y, Lu H, Yang P, et al. (2011). Phosphoproteome analysis reveals regulatory sites in major pathways of cardiac mitochondria. Mol Cell Proteomics, 10: M110 000117
142. Schulenberg B, Aggeler R, Beechem JM, Capaldi RA, Patton WF (2003). Analysis of steady-state protein phosphorylation in mitochondria using a novel fluorescent phosphosensor dye. J Biol Chem, 278: 27251-27255
143. Chen R, Fearnley IM, Peak-Chew SY, Walker JE (2004). The phosphorylation of subunits of complex I from bovine heart mitochondria. The Journal of biological chemistry, 279: 26036-26045
144. Steenaart NA, Shore GC (1997). Mitochondrial cytochrome c oxidase subunit IV is phosphorylated by an endogenous kinase. FEBS Lett, 415: 294-298
145. Ko YH, Pan W, Inoue C, Pedersen PL (2002). Signal transduction to mitochondrial ATP synthase: evidence that PDGF-dependent phosphorylation of the delta-subunit occurs in several cell lines, involves tyrosine, and is modulated by lysophosphatidic acid. Mitochondrion, 1: 339-348
146. Salvi M, Morrice NA, Brunati AM, Toninello A (2007). Identification of the flavoprotein of succinate dehydrogenase and aconitase as in vitro mitochondrial substrates of Fgr tyrosine kinase. FEBS Lett, 581: 5579-5585
147. Jakob S, Altschmied J, Haendeler J (2009). "Shping 2" different cellular localizations - a potential new player in aging processes. Aging, 1: 664-668
148. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ (2003). Production of reactive oxygen species by mitochondria: central role of complex III. The Journal of biological chemistry, 278: 36027-36031
149. Hebert-Chatelain E, Jose C, Gutierrez Cortes N, Dupuy JW, Rocher C, Dachary-Prigent J, et al. (2012). Preservation of NADH ubiquinone-oxidoreductase activity by Src kinase-mediated phosphorylation of NDUFB10. Biochimica et biophysica acta, 1817: 718-725
150. Hebert Chatelain E, Dupuy JW, Letellier T, Dachary-Prigent J (2011). Functional impact of PTP1B-mediated Src regulation on oxidative phosphorylation in rat brain mitochondria. Cell Mol Life Sci, 68: 2603-2613
151. Reznick RM, Shulman GI (2006). The role of AMP-activated protein kinase in mitochondrial biogenesis. The Journal of physiology, 574: 33-39
152. Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, et al. (2007). Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell metabolism, 5: 151-156
153. Nemoto S, Combs CA, French S, Ahn BH, Fergusson MM, Balaban RS, et al. (2006). The mammalian longevity-associated gene product p66shc regulates mitochondrial metabolism. The Journal of biological chemistry, 281: 10555-10560
154. Cosentino F, Francia P, Camici GG, Pelicci PG, Luscher TF, Volpe M (2008). Final common molecular pathways of aging and cardiovascular disease: role of the p66Shc protein. Arteriosclerosis, thrombosis, and vascular biology, 28: 622-628
155. Rinaldi S, Landucci F, De Gaudio AR (2009). Antioxidant therapy in critically septic patients. Curr Drug Targets, 10: 872-880
156. Andrades ME, Ritter C, Dal-Pizzol F (2009). The role of free radicals in sepsis development. Front Biosci (Elite Ed), 1: 277-287
157. Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F (2004). Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Critical care medicine, 32: 342-349
158. Long CL, Maull KI, Krishnan RS, Laws HL, Geiger JW, Borghesi L, et al. (2003). Ascorbic acid dynamics in the seriously ill and injured. The Journal of surgical research, 109: 144-148
159. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, et al. (2007). Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med, 35: 118-126
160. Forceville X, Laviolle B, Annane D, Vitoux D, Bleichner G, Korach JM, et al. (2007). Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care, 11: R73
161. Berger MM, Chiolero RL (2007). Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Critical care medicine, 35: S584-590
162. Lovat R, Preiser JC (2003). Antioxidant therapy in intensive care. Curr Opin Crit Care, 9: 266-270
163. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, et al. (2005). Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 19: 1088-1095
164. Szeto HH (2006). Cell-permeable, mitochondrial-targeted, peptide antioxidants. AAPS J, 8: E277-283
165. Amstislavskaya TG, Maslova LN, Gladkikh DV, Belousova, II, Stefanova NA, Kolosova NG Effects of the mitochondria-targeted antioxidant SkQ1 on sexually motivated behavior in male rats. Pharmacol Biochem Behav,
166. Demianenko IA, Vasilieva TV, Domnina LV, Dugina VB, Egorov MV, Ivanova OY, et al. Novel mitochondria-targeted antioxidants, "Skulachev-ion" derivatives, accelerate dermal wound healing in animals. Biochemistry. Biokhimiia, 75: 274-280
167. Coulter CV, Kelso GF, Lin TK, Smith RA, Murphy MP (2000). Mitochondrially targeted antioxidants and thiol reagents. Free radical biology & medicine, 28: 1547-1554
168. Murphy MP, Smith RA (2007). Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annual review of pharmacology and toxicology, 47: 629-656
169. Smith RA, Porteous CM, Gane AM, Murphy MP (2003). Delivery of bioactive molecules to mitochondria in vivo. Proceedings of the National Academy of Sciences of the United States of America, 100: 5407-5412
170. Szeto HH (2008). Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxidants & redox signaling, 10: 601-619
171. Lowes DA, Wallace C, Murphy MP, Webster NR, Galley HF (2009). The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells. Free radical research, 43: 323-328
172. Dhanasekaran A, Kotamraju S, Kalivendi SV, Matsunaga T, Shang T, Keszler A, et al. (2004). Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. J Biol Chem, 279: 37575-37587
173. Dhanasekaran A, Kotamraju S, Karunakaran C, Kalivendi SV, Thomas S, Joseph J, et al. (2005). Mitochondria superoxide dismutase mimetic inhibits peroxide-induced oxidative damage and apoptosis: role of mitochondrial superoxide. Free Radic Biol Med, 39: 567-583
174. Jauslin ML, Meier T, Smith RA, Murphy MP (2003). Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J, 17: 1972-1974
175. Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, et al. (2010). The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Liver international: official journal of the International Association for the Study of the Liver, 30: 1019-1026
176. Smith RA, Murphy MP (2010). Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of the New York Academy of Sciences, 1201: 96-103
177. Ghosh A, Chandran K, Kalivendi SV, Joseph J, Antholine WE, Hillard CJ, et al. (2010). Neuroprotection by a mitochondria-targeted drug in a Parkinson's disease model. Free radical biology & medicine, 49: 1674-1684
178. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, et al. (2010). Mitochondria-targeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. Journal of Alzheimer's disease: JAD, 20 Suppl 2: S609-631
179. Chandran K, Aggarwal D, Migrino RQ, Joseph J, McAllister D, Konorev EA, et al. (2009). Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. Biophys J, 96: 1388-1398
180. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, et al. Therapeutic targeting of mitochondrial superoxide in hypertension. Circulation research, 107: 106-116
181. Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, et al. (2010). Prevention of diabetic nephropathy in Ins2(+/)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. The Biochemical journal, 432: 9-19
182. Lowes DA, Thottakam BM, Webster NR, Murphy MP, Galley HF (2008). The mitochondria-targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free radical biology & medicine, 45: 1559-1565
183. Supinski GS, Murphy MP, Callahan LA (2009). MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol, 297: R1095-1102
184. Antonenko YN, Avetisyan AV, Bakeeva LE, Chernyak BV, Chertkov VA, Domnina LV, et al. (2008). Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry. Biokhimiia, 73: 1273-1287
185. Stefanova NA, Fursova A, Kolosova NG (2010). Behavioral effects induced by mitochondria-targeted antioxidant SkQ1 in Wistar and senescence-accelerated OXYS rats. Journal of Alzheimer's disease: JAD, 21: 479-491
186. Shipounova IN, Svinareva DA, Petrova TV, Lyamzaev KG, Chernyak BV, Drize NI, et al. (2010). Reactive oxygen species produced in mitochondria are involved in age-dependent changes of hematopoietic and mesenchymal progenitor cells in mice. A study with the novel mitochondria-targeted antioxidant SkQ1. Mechanisms of ageing and development, 131: 415-421
187. Krementsova AV, Roshina NV, Tsybul'ko EA, Rybina OY, Symonenko AV, Pasyukova EG (2012). Reproducible effects of the mitochondria-targeted plastoquinone derivative SkQ1 on Drosophila melanogaster lifespan under different experimental scenarios. Biogerontology, 13: 595-607
188. Anisimov VN, Egorov MV, Krasilshchikova MS, Lyamzaev KG, Manskikh VN, Moshkin MP, et al. (2011). Effects of the mitochondria-targeted antioxidant SkQ1 on lifespan of rodents. Aging, 3: 1110-1119
189. Venkataraman R, Subramanian S, Kellum JA (2003). Clinical review: extracorporeal blood purification in severe sepsis. Crit Care, 7: 139-145